Cart
sales@molnova.com
Namirotene
CAS No. 101506-83-6
Namirotene( —— )
Catalog No. M34662 CAS No. 101506-83-6
Namirotene (CBS 211A) is a protein biosynthesis inhibitor, a synthetic retinoic acid analog that is used in the study of corneal diseases, corneal ulcers and dry eye syndrome.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 170 | In Stock |
|
| 10MG | 257 | In Stock |
|
| 25MG | 481 | In Stock |
|
| 50MG | 632 | In Stock |
|
| 100MG | 921 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1841 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNamirotene
-
NoteResearch use only, not for human use.
-
Brief DescriptionNamirotene (CBS 211A) is a protein biosynthesis inhibitor, a synthetic retinoic acid analog that is used in the study of corneal diseases, corneal ulcers and dry eye syndrome.
-
DescriptionNamirotene (CBS 211A) is a protein biosynthesis inhibitor, a synthetic retinoic acid analog that is used in the study of corneal diseases, corneal ulcers and dry eye syndrome.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number101506-83-6
-
Formula Weight286.39
-
Molecular FormulaC17H18O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C\C1=CC=C(C(O)=O)C=C1)(\C)/C=2SC(C(C)C)=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BTM - P1
BTM - P1
-
Pomalidomide-C4-COOH
Pomalidomide-C4-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
N-Acetyl-L-aspartic ...
N-Acetylaspartic acid is a derivative of aspartic acid. It is the second most concentrated molecule in the brain after the amino acid glutamate. It is synthesized in neurons from the amino acid aspartate and acetyl coenzyme A (acetyl CoA).
